D. Price (Aberdeen, United Kingdom), B. Cosio (Palma De Mallorca, Spain)
How far is real life from COPD therapy guidelines? An observational study on 4000 patients in Italy
A. Rossi, M. Dottorini, R. Vincenti, G. Santelli, A. Corrado, on Behalf of the COPD3-AIPO Study Group (Verona, Perugia, Carrara, Treviso, Florence, Italy)
|  |
What represents a meaningful improvement in symptom-free days (SFD) and rescue-free days (RFD)? The patient‘s perspective
S. Martin, R. Stanford, P. Dale, S. Fehnl (Ann Arbor, RTP, United States Of America; London, United Kingdom)
| |
The use of an electronic health record improves asthma clinical outcomes
J. Bozzola, J. Arcos, S. Tagliafico, C. Rodriguez, L. Piñeyro (Montevideo, Uruguay)
|  |
The minimal important difference in symptoms and rescue free days
S. Tomkins, L. Frith, L. Jacques, R. Stanford, P. Dale (Stevenage, London, United Kingdom; RTP, United States Of America)
| |
Asthma control with inhaled corticosteroid therapy: A real-world observational study
D. Price, N. Barnes, N. Roche, G. Colice, A. J. Lee (Aberdeen, United Kingdom; Paris, France; Washington, United States Of America)
| |
Patient baseline variables predict future asthma control status and risk of exacerbations
R. Buhl, P. O‘Byrne, M. Humbert, S. Peterson, G. S. Eriksson (Germany; Hamilton, Canada; Clamart, France; Lund, Sweden)
| |
Underrepresentation of patients with cardiovascular diseases in trials of chronic obstructive pulmonary disease: Transferability problems in general practice?
O. Capelli, E. Patorno, S. Riccomi, C. Voci, A. M. Marata (Italy)
| |
Vagal response to simulated acid reflux in a population of adult asthmatics
D. L. Amarasiri, A. Pathmeswaran, H. J. De Silva, C. D. Ranasinha (Ragama, Sri Lanka)
| |
Long-term follow-up of patients under omalizumab initiated during the pre-approval period in France
M. Molimard, P. Chanez, C. Pison, L. Tétu, V. Le Gros (Marseille, Grenoble, Toulouse, Rueil-Malmaison, France)
| |
Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study
E. Koster, J. Raaijmakers, A. H. Maitland-van der Zee (Utrecht, Netherlands)
| |
Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice
C. L. Chang, J. Stephenson, S. Sajjan, E. Maiese, F. Allen-Ramey (West Point, Wilmington, United States Of America)
| |
Switching asthma patients using high-dose inhaled steroids to budesonide/formoterol maintenance and reliever therapy
R. Buhl, J. Haughney, O. C. P. van Schayck, J. Ostinelli, T. Ekström, L. Jörgensen, M. Aubier (Germany; Aberdeen, United Kingdom; , Netherlands; Rueil-Malmaison, Paris, France; Södertälje, Sweden)
| |
Guideline adherence in treatment of COPD
I. Sarc, T. Jeric, K. Ziherl, M. Kosnik, S. D. Anker, M. Lainscak (Golnik, Slovenia; Berlin, Germany)
| |
Risks of pneumonia in asthmatic patients taking inhaled corticosteroids
P. O‘Byrne, S. Pedersen, F. Radner, A. Thoren, L. G. Carlsson, P. Ernst (Hamilton, Montreal, Canada; , Denmark; Lund, Sweden)
| |
Interactions between roflumilast and cytochrome P450 inducers and inhibitors: Overview of existing studies
G. Lahu, A. Hünnemeyer, N. Nassr, N. McCracken (Konstanz, Germany)
| |
Financial benefits of fluticasone propionate/salmeterol 250/50 mcg fixed dose combination over tiotropium in elderly managed COPD patient
S. M. A. Mamun (Dhaka, Bangladesh)
| |
Improvement of asthma treatment in young adults during 1997-2006? An observational study covering the entire Danish population
J. R. Davidsen, J. Søndergaard, J. Hallas, H. C. Siersted, J. Lykkegaard, M. Andersen (Odense, Denmark; Stockholm, Sweden)
| |
Managing the challenges of spirometry in multi center clinical trials
D. Price, J. Robinson, M. Larbig, P. Quanjer (Horsham, United Kingdom; Rotterdam, Netherlands)
| |
Nebulised hypertonic (7%) saline improves quality of life in a blinded randomised cross-over trial
F. Kellett, R. Niven, R. Niven (Warrington, United Kingdom)
| |
Comparative evaluation of desloratadine versus levocetirizine in managing patients with comorbid rhinitis and asthma in the United Kingdom
J. McLaughlin, C. de Moor, G. Reardon, P. Navaratnam (Columbus, United States Of America)
| |